A study presented at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening in multiple ...

Most people with multiple sclerosis (MS) have a type called relapsing-remitting MS (RRMS). It usually starts in your 20s or 30s. One study shows that people who began treatment when their first ...

"Those with the highest burden of comorbidity had over a 30% increased risk of having disability worsening," Salter said. "In ...

Generally, evidence notes that hypersexuality with multiple sclerosis (MS) is uncommon. A 2024 review investigating hypersexuality in neurological disorders wanted to include MS, but did not as ...

Patients will be able to get a 10 minute injection of the Roche drug, instead of an hours-long infusion. Novartis already has ...

Aug. 23, 2024 — A collaborative investigation among experts in Alzheimer's disease and multiple sclerosis (MS) finds evidence that MS patients are less likely to have amyloid plaques ...

The mission of the UAB Multiple Sclerosis Center is to foster research, clinical and educational activities in the area of neuroimmunology with an emphasis on Multiple Sclerosis. The faculty and staff ...

Although there is currently no cure for multiple sclerosis (MS), current treatments focus on limiting further damage, easing symptoms, and avoiding complications. If you have a type of multiple ...

Nearly three million people around the world have multiple sclerosis. Scientists think they have now uncovered a mystery cause of this incurable disease. It is a virus that nearly every one of us ...

New research presented today at European Committee for Treatment and Research in Multiple Sclerosis 2024 reveals that ...

Sanofi’s experimental drug for a form of multiple sclerosis delayed the progression of disability by nearly a third, ...

At Baylor Medicine's Maxine Mesinger Multiple Sclerosis Clinic specialized physicians provide diagnostics, treatment and support services to MS patients at a single, easy access location. Our ...